Global Carcinoid Syndrome Management Market Size, Status and Forecast 2021-2027
- Published Date : 04-06-2021
- Pages : 95
- Report Id : 33008
- Categories : Healthcare
Carcinoid syndrome comprises of signs and symptoms including flushing of the face, debilitating diarrhea, asthma caused due to vasoconstriction, intestinal bleeding, fast heartbeat, shortness of breath, sweating, unexplained weight gain etc. which are settled secondary to carcinoid tumor.
The management or treatment of carcinoid syndrome often requires palliative and supportive care. Management of carcinoid syndrome involves drug therapy or surgical removal of carcinoid tumor from the organ.
In 2020, the global Carcinoid Syndrome Management market size was xx million US$ and it is expected to reach xx million US$ by the end of 2027, with a CAGR of xx% during 2021-2027.
This report focuses on the global Carcinoid Syndrome Management status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Carcinoid Syndrome Management development in United States, Europe and China.
The key players covered in this study
Novartis
Omega Laboratories
Teva Pharmaceutical
Mylan
Ipsen Biopharmaceuticals
Sirtex Medical
BTG International
Wockhardt
Sun Pharmaceutical
Market segment by Type, the product can be split into
Chemotherapy
Biological Therapy
Hepatic Artery Embolization Agents
Market segment by Application, split into
Hospitals
Clinics
Cancer Institute and Treatment Centers
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Carcinoid Syndrome Management status, future forecast, growth opportunity, key market and key players.
To present the Carcinoid Syndrome Management development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Carcinoid Syndrome Management are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Carcinoid Syndrome Management Market Size Growth Rate by Type ( 2016-2027)
1.4.2 Chemotherapy
1.4.3 Biological Therapy
1.4.4 Hepatic Artery Embolization Agents
1.5 Market by Application
1.5.1 Global Carcinoid Syndrome Management Market Share by Application ( 2016-2027)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Cancer Institute and Treatment Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Carcinoid Syndrome Management Market Size
2.2 Carcinoid Syndrome Management Growth Trends by Regions
2.2.1 Carcinoid Syndrome Management Market Size by Regions ( 2016-2027)
2.2.2 Carcinoid Syndrome Management Market Share by Regions ( 2016-2021)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Carcinoid Syndrome Management Market Size by Manufacturers
3.1.1 Global Carcinoid Syndrome Management Revenue by Manufacturers ( 2016-2021)
3.1.2 Global Carcinoid Syndrome Management Revenue Market Share by Manufacturers ( 2016-2021)
3.1.3 Global Carcinoid Syndrome Management Market Concentration Ratio (CR5 and HHI)
3.2 Carcinoid Syndrome Management Key Players Head office and Area Served
3.3 Key Players Carcinoid Syndrome Management Product/Solution/Service
3.4 Date of Enter into Carcinoid Syndrome Management Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Carcinoid Syndrome Management Market Size by Type ( 2016-2021)
4.2 Global Carcinoid Syndrome Management Market Size by Application ( 2016-2021)
5 United States
5.1 United States Carcinoid Syndrome Management Market Size ( 2016-2021)
5.2 Carcinoid Syndrome Management Key Players in United States
5.3 United States Carcinoid Syndrome Management Market Size by Type
5.4 United States Carcinoid Syndrome Management Market Size by Application
6 Europe
6.1 Europe Carcinoid Syndrome Management Market Size ( 2016-2021)
6.2 Carcinoid Syndrome Management Key Players in Europe
6.3 Europe Carcinoid Syndrome Management Market Size by Type
6.4 Europe Carcinoid Syndrome Management Market Size by Application
7 China
7.1 China Carcinoid Syndrome Management Market Size ( 2016-2021)
7.2 Carcinoid Syndrome Management Key Players in China
7.3 China Carcinoid Syndrome Management Market Size by Type
7.4 China Carcinoid Syndrome Management Market Size by Application
8 Japan
8.1 Japan Carcinoid Syndrome Management Market Size ( 2016-2021)
8.2 Carcinoid Syndrome Management Key Players in Japan
8.3 Japan Carcinoid Syndrome Management Market Size by Type
8.4 Japan Carcinoid Syndrome Management Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Carcinoid Syndrome Management Market Size ( 2016-2021)
9.2 Carcinoid Syndrome Management Key Players in Southeast Asia
9.3 Southeast Asia Carcinoid Syndrome Management Market Size by Type
9.4 Southeast Asia Carcinoid Syndrome Management Market Size by Application
10 India
10.1 India Carcinoid Syndrome Management Market Size ( 2016-2021)
10.2 Carcinoid Syndrome Management Key Players in India
10.3 India Carcinoid Syndrome Management Market Size by Type
10.4 India Carcinoid Syndrome Management Market Size by Application
11 Central & South America
11.1 Central & South America Carcinoid Syndrome Management Market Size ( 2016-2021)
11.2 Carcinoid Syndrome Management Key Players in Central & South America
11.3 Central & South America Carcinoid Syndrome Management Market Size by Type
11.4 Central & South America Carcinoid Syndrome Management Market Size by Application
12 International Players Profiles
12.1 Novartis
12.1.1 Novartis Company Details
12.1.2 Company Description and Business Overview
12.1.3 Carcinoid Syndrome Management Introduction
12.1.4 Novartis Revenue in Carcinoid Syndrome Management Business ( 2016-2021)
12.1.5 Novartis Recent Development
12.2 Omega Laboratories
12.2.1 Omega Laboratories Company Details
12.2.2 Company Description and Business Overview
12.2.3 Carcinoid Syndrome Management Introduction
12.2.4 Omega Laboratories Revenue in Carcinoid Syndrome Management Business ( 2016-2021)
12.2.5 Omega Laboratories Recent Development
12.3 Teva Pharmaceutical
12.3.1 Teva Pharmaceutical Company Details
12.3.2 Company Description and Business Overview
12.3.3 Carcinoid Syndrome Management Introduction
12.3.4 Teva Pharmaceutical Revenue in Carcinoid Syndrome Management Business ( 2016-2021)
12.3.5 Teva Pharmaceutical Recent Development
12.4 Mylan
12.4.1 Mylan Company Details
12.4.2 Company Description and Business Overview
12.4.3 Carcinoid Syndrome Management Introduction
12.4.4 Mylan Revenue in Carcinoid Syndrome Management Business ( 2016-2021)
12.4.5 Mylan Recent Development
12.5 Ipsen Biopharmaceuticals
12.5.1 Ipsen Biopharmaceuticals Company Details
12.5.2 Company Description and Business Overview
12.5.3 Carcinoid Syndrome Management Introduction
12.5.4 Ipsen Biopharmaceuticals Revenue in Carcinoid Syndrome Management Business ( 2016-2021)
12.5.5 Ipsen Biopharmaceuticals Recent Development
12.6 Sirtex Medical
12.6.1 Sirtex Medical Company Details
12.6.2 Company Description and Business Overview
12.6.3 Carcinoid Syndrome Management Introduction
12.6.4 Sirtex Medical Revenue in Carcinoid Syndrome Management Business ( 2016-2021)
12.6.5 Sirtex Medical Recent Development
12.7 BTG International
12.7.1 BTG International Company Details
12.7.2 Company Description and Business Overview
12.7.3 Carcinoid Syndrome Management Introduction
12.7.4 BTG International Revenue in Carcinoid Syndrome Management Business ( 2016-2021)
12.7.5 BTG International Recent Development
12.8 Wockhardt
12.8.1 Wockhardt Company Details
12.8.2 Company Description and Business Overview
12.8.3 Carcinoid Syndrome Management Introduction
12.8.4 Wockhardt Revenue in Carcinoid Syndrome Management Business ( 2016-2021)
12.8.5 Wockhardt Recent Development
12.9 Sun Pharmaceutical
12.9.1 Sun Pharmaceutical Company Details
12.9.2 Company Description and Business Overview
12.9.3 Carcinoid Syndrome Management Introduction
12.9.4 Sun Pharmaceutical Revenue in Carcinoid Syndrome Management Business ( 2016-2021)
12.9.5 Sun Pharmaceutical Recent Development
13 Market Forecast 2021-2027
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product ( 2021-2027)
13.10 Market Size Forecast by Application ( 2021-2027)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
Table Carcinoid Syndrome Management Key Market Segments
Table Key Players Carcinoid Syndrome Management Covered
Table Global Carcinoid Syndrome Management Market Size Growth Rate by Type 2016-2027 (Million US$)
Figure Global Carcinoid Syndrome Management Market Size Market Share by Type 2016-2027
Figure Chemotherapy Figures
Table Key Players of Chemotherapy
Figure Biological Therapy Figures
Table Key Players of Biological Therapy
Figure Hepatic Artery Embolization Agents Figures
Table Key Players of Hepatic Artery Embolization Agents
Table Global Carcinoid Syndrome Management Market Size Growth by Application 2016-2027 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Cancer Institute and Treatment Centers Case Studies
Figure Carcinoid Syndrome Management Report Years Considered
Table Global Carcinoid Syndrome Management Market Size 2016-2027 (Million US$)
Figure Global Carcinoid Syndrome Management Market Size and Growth Rate 2016-2027 (Million US$)
Table Global Carcinoid Syndrome Management Market Size by Regions 2016-2027 (Million US$)
Table Global Carcinoid Syndrome Management Market Size by Regions 2016-2021 (Million US$)
Table Global Carcinoid Syndrome Management Market Share by Regions 2016-2021
Figure Global Carcinoid Syndrome Management Market Share by Regions 2016-2021
Figure Global Carcinoid Syndrome Management Market Share by Regions 2019
Table Market Top Trends
Table Global Carcinoid Syndrome Management Revenue by Manufacturers ( 2016-2021) (Million US$)
Table Global Carcinoid Syndrome Management Market Share by Manufacturers ( 2016-2021)
Figure Global Carcinoid Syndrome Management Market Share by Manufacturers in 2020
Table Global Carcinoid Syndrome Management Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Carcinoid Syndrome Management Product/Solution/Service
Table Date of Enter into Carcinoid Syndrome Management Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Carcinoid Syndrome Management Market Size by Type ( 2016-2021) (Million US$)
Table Global Carcinoid Syndrome Management Market Size Share by Type ( 2016-2021)
Figure Global Carcinoid Syndrome Management Market Size Market Share by Type ( 2016-2021)
Table Global Carcinoid Syndrome Management Market Size by Application ( 2016-2021) (Million US$)
Table Global Carcinoid Syndrome Management Market Size Share by Application ( 2016-2021)
Figure Global Carcinoid Syndrome Management Market Size Market Share by Application ( 2016-2021)
Figure Global Carcinoid Syndrome Management Revenue Market Share by Application in 2020
Figure United States Carcinoid Syndrome Management Market Size 2016-2021 (Million US$)
Table United States Key Players Carcinoid Syndrome Management Revenue ( 2020-2021) (Million US$)
Table United States Key Players Carcinoid Syndrome Management Market Share ( 2020-2021)
Table United States Carcinoid Syndrome Management Market Size by Type ( 2016-2021) (Million US$)
Table United States Carcinoid Syndrome Management Market Share by Type ( 2016-2021)
Table United States Carcinoid Syndrome Management Market Size by Application ( 2016-2021) (Million US$)
Table United States Carcinoid Syndrome Management Market Share by Application ( 2016-2021)
Figure Europe Carcinoid Syndrome Management Market Size 2016-2021 (Million US$)
Table Europe Key Players Carcinoid Syndrome Management Revenue ( 2020-2021) (Million US$)
Table Europe Key Players Carcinoid Syndrome Management Market Share ( 2020-2021)
Table Europe Carcinoid Syndrome Management Market Size by Type ( 2016-2021) (Million US$)
Table Europe Carcinoid Syndrome Management Market Share by Type ( 2016-2021)
Table Europe Carcinoid Syndrome Management Market Size by Application ( 2016-2021) (Million US$)
Table Europe Carcinoid Syndrome Management Market Share by Application ( 2016-2021)
Figure China Carcinoid Syndrome Management Market Size 2016-2021 (Million US$)
Table China Key Players Carcinoid Syndrome Management Revenue ( 2020-2021) (Million US$)
Table China Key Players Carcinoid Syndrome Management Market Share ( 2020-2021)
Table China Carcinoid Syndrome Management Market Size by Type (2014- 20209) (Million US$)
Table China Carcinoid Syndrome Management Market Share by Type ( 2016-2021)
Table China Carcinoid Syndrome Management Market Size by Application ( 2016-2021) (Million US$)
Table China Carcinoid Syndrome Management Market Share by Application ( 2016-2021)
Figure Japan Carcinoid Syndrome Management Market Size 2016-2021 (Million US$)
Table Japan Key Players Carcinoid Syndrome Management Revenue ( 2020-2021) (Million US$)
Table Japan Key Players Carcinoid Syndrome Management Market Share ( 2020-2021)
Table Japan Carcinoid Syndrome Management Market Size by Type ( 2016-2021) (Million US$)
Table Japan Carcinoid Syndrome Management Market Share by Type ( 2016-2021)
Table Japan Carcinoid Syndrome Management Market Size by Application ( 2016-2021) (Million US$)
Table Japan Carcinoid Syndrome Management Market Share by Application ( 2016-2021)
Figure Southeast Asia Carcinoid Syndrome Management Market Size 2016-2021 (Million US$)
Table Southeast Asia Key Players Carcinoid Syndrome Management Revenue ( 2020-2021) (Million US$)
Table Southeast Asia Key Players Carcinoid Syndrome Management Market Share ( 2020-2021)
Table Southeast Asia Carcinoid Syndrome Management Market Size by Type ( 2016-2021) (Million US$)
Table Southeast Asia Carcinoid Syndrome Management Market Share by Type ( 2016-2021)
Table Southeast Asia Carcinoid Syndrome Management Market Size by Application ( 2016-2021) (Million US$)
Table Southeast Asia Carcinoid Syndrome Management Market Share by Application ( 2016-2021)
Figure India Carcinoid Syndrome Management Market Size 2016-2021 (Million US$)
Table India Key Players Carcinoid Syndrome Management Revenue ( 2020-2021) (Million US$)
Table India Key Players Carcinoid Syndrome Management Market Share ( 2020-2021)
Table India Carcinoid Syndrome Management Market Size by Type ( 2016-2021) (Million US$)
Table India Carcinoid Syndrome Management Market Share by Type ( 2016-2021)
Table India Carcinoid Syndrome Management Market Size by Application ( 2016-2021) (Million US$)
Table India Carcinoid Syndrome Management Market Share by Application ( 2016-2021)
Figure Central & South America Carcinoid Syndrome Management Market Size 2016-2021 (Million US$)
Table Central & South America Key Players Carcinoid Syndrome Management Revenue ( 2020-2021) (Million US$)
Table Central & South America Key Players Carcinoid Syndrome Management Market Share ( 2020-2021)
Table Central & South America Carcinoid Syndrome Management Market Size by Type ( 2016-2021) (Million US$)
Table Central & South America Carcinoid Syndrome Management Market Share by Type ( 2016-2021)
Table Central & South America Carcinoid Syndrome Management Market Size by Application ( 2016-2021) (Million US$)
Table Central & South America Carcinoid Syndrome Management Market Share by Application ( 2016-2021)
Table Novartis Company Details
Table Novartis Revenue in Carcinoid Syndrome Management Business ( 2016-2021) (Million US$)
Figure Novartis Revenue Growth Rate in Carcinoid Syndrome Management Business ( 2016-2021)
Table Novartis Recent Development
Table Omega Laboratories Company Details
Table Omega Laboratories Revenue in Carcinoid Syndrome Management Business ( 2016-2021)(Million US$)
Figure Omega Laboratories Revenue Growth Rate in Carcinoid Syndrome Management Business ( 2016-2021)
Table Omega Laboratories Recent Development
Table Teva Pharmaceutical Company Details
Table Teva Pharmaceutical Revenue in Carcinoid Syndrome Management Business ( 2016-2021)(Million US$)
Figure Teva Pharmaceutical Revenue Growth Rate in Carcinoid Syndrome Management Business ( 2016-2021)
Table Teva Pharmaceutical Recent Development
Table Mylan Company Details
Table Mylan Revenue in Carcinoid Syndrome Management Business ( 2016-2021)(Million US$)
Figure Mylan Revenue Growth Rate in Carcinoid Syndrome Management Business ( 2016-2021)
Table Mylan Recent Development
Table Ipsen Biopharmaceuticals Company Details
Table Ipsen Biopharmaceuticals Revenue in Carcinoid Syndrome Management Business ( 2016-2021)(Million US$)
Figure Ipsen Biopharmaceuticals Revenue Growth Rate in Carcinoid Syndrome Management Business ( 2016-2021)
Table Ipsen Biopharmaceuticals Recent Development
Table Sirtex Medical Company Details
Table Sirtex Medical Revenue in Carcinoid Syndrome Management Business ( 2016-2021)(Million US$)
Figure Sirtex Medical Revenue Growth Rate in Carcinoid Syndrome Management Business ( 2016-2021)
Table Sirtex Medical Recent Development
Table BTG International Company Details
Table BTG International Revenue in Carcinoid Syndrome Management Business ( 2016-2021)(Million US$)
Figure BTG International Revenue Growth Rate in Carcinoid Syndrome Management Business ( 2016-2021)
Table BTG International Recent Development
Table Wockhardt Company Details
Table Wockhardt Revenue in Carcinoid Syndrome Management Business ( 2016-2021)(Million US$)
Figure Wockhardt Revenue Growth Rate in Carcinoid Syndrome Management Business ( 2016-2021)
Table Wockhardt Recent Development
Table Sun Pharmaceutical Company Details
Table Sun Pharmaceutical Revenue in Carcinoid Syndrome Management Business ( 2016-2021)(Million US$)
Figure Sun Pharmaceutical Revenue Growth Rate in Carcinoid Syndrome Management Business ( 2016-2021)
Table Sun Pharmaceutical Recent Development
Table Global Carcinoid Syndrome Management Market Size by Regions (Million US$) 2021-2027
Figure Global Carcinoid Syndrome Management Market Size Share by Regions ( 2021-2027)
Figure Global Carcinoid Syndrome Management Market Size Share by Regions in 2027
Figure United States Carcinoid Syndrome Management Market Size Forecast ( 2021-2027)(Million USD)
Figure Europe Carcinoid Syndrome Management Market Size Forecast ( 2021-2027)(Million USD)
Figure China Carcinoid Syndrome Management Market Size Forecast ( 2021-2027)(Million USD)
Figure Japan Carcinoid Syndrome Management Market Size Forecast ( 2021-2027)(Million USD)
Figure Southeast Asia Carcinoid Syndrome Management Market Size Forecast ( 2021-2027)(Million USD)
Figure India Carcinoid Syndrome Management Market Size Forecast ( 2021-2027)(Million USD)
Figure Central & South America Carcinoid Syndrome Management Market Size Forecast ( 2021-2027)(Million USD)
Table Global Carcinoid Syndrome Management Market Size by Product ( 2021-2027) (Million US$)
Figure Global Carcinoid Syndrome Management Market Size by Product ( 2021-2027)
Figure Global Carcinoid Syndrome Management Market Size by Product in 2027
Table Global Carcinoid Syndrome Management Market Size by Application ( 2021-2027) (Million US$)
Figure Global Carcinoid Syndrome Management Market Size by Application ( 2021-2027)
Figure Global Carcinoid Syndrome Management Market Size by Application in 2027
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Direct Purchase
Your perfect start with Research AlliedWant to customize this report?
This report can be customized according to your requirements. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.
Avail PDF Sample Reports
You may also be lnterested in..
Research Allied ™ Copyright © 2025 .